Ulcerative Colitis: Current and Emerging Treatment Strategies
- PMID: 31905945
- PMCID: PMC7019865
- DOI: 10.3390/jcm9010094
Ulcerative Colitis: Current and Emerging Treatment Strategies
Abstract
Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids. Excitingly, over the past just 1-2 decades, the options for medical therapy have expanded and include biologics and small molecules, with more agents actively being developed. In this article, we review the current and emerging treatment strategies for UC stratified according to disease severity.
Keywords: biologic; colectomy; small molecule; ulcerative colitis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Update on the Use of Biologic Therapy in Ulcerative Colitis.Curr Treat Options Gastroenterol. 2017 Mar;15(1):155-167. doi: 10.1007/s11938-017-0120-8. Curr Treat Options Gastroenterol. 2017. PMID: 28120279 Review.
-
Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis.Aliment Pharmacol Ther. 2015 Jun;41(11):1094-103. doi: 10.1111/apt.13175. Epub 2015 Mar 23. Aliment Pharmacol Ther. 2015. PMID: 25809869 Free PMC article. Review.
-
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis.J Clin Med. 2022 Apr 20;11(9):2302. doi: 10.3390/jcm11092302. J Clin Med. 2022. PMID: 35566428 Free PMC article. Review.
-
Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new?World J Gastrointest Surg. 2016 Sep 27;8(9):598-605. doi: 10.4240/wjgs.v8.i9.598. World J Gastrointest Surg. 2016. PMID: 27721922 Free PMC article. Review.
-
Management of Ulcerative Colitis in the Elderly.Drugs Aging. 2019 Jan;36(1):13-27. doi: 10.1007/s40266-018-0611-x. Drugs Aging. 2019. PMID: 30515708 Review.
Cited by
-
Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis.Evid Based Complement Alternat Med. 2021 Jun 9;2021:5548764. doi: 10.1155/2021/5548764. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34211567 Free PMC article. Review.
-
Bacillus clausii spores maintain gut homeostasis in murine ulcerative colitis via modulating microbiota, apoptosis, and the TXNIP/NLRP3 inflammasome cascade.Toxicol Rep. 2024 Dec 16;14:101858. doi: 10.1016/j.toxrep.2024.101858. eCollection 2025 Jun. Toxicol Rep. 2024. PMID: 39802600 Free PMC article.
-
Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling.Inflammopharmacology. 2024 Dec;32(6):3881-3898. doi: 10.1007/s10787-024-01527-7. Epub 2024 Aug 12. Inflammopharmacology. 2024. PMID: 39134818 Free PMC article.
-
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition.Pharmaceuticals (Basel). 2021 Apr 8;14(4):341. doi: 10.3390/ph14040341. Pharmaceuticals (Basel). 2021. PMID: 33917884 Free PMC article.
-
Hydrogel-metal-organic-framework hybrids mediated efficient oral delivery of siRNA for the treatment of ulcerative colitis.J Nanobiotechnology. 2022 Sep 5;20(1):404. doi: 10.1186/s12951-022-01603-6. J Nanobiotechnology. 2022. PMID: 36064365 Free PMC article.
References
-
- Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.-F., Gasche C., Geboes K., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005;19(Suppl. A):5a–36a. doi: 10.1155/2005/269076. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous